Načítá se...
Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis
Immune/inflammatory cells act in rheumatoid arthritis (RA)-affected patients by synthesizing several inflammatory mediators, including cytokines that initiate intracellular signaling. Recently, small molecule inhibitors of transduction and transcription signals that influence the intracellular pathw...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3890964/ https://ncbi.nlm.nih.gov/pubmed/24453498 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JIR.S35901 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|